BATE KENNETH
SEC CIK 1210238 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Dir | 19.2K | — | $27.02M | 11 | 2023-06-15 | 2025-11-05 |
Most active insiders at MDGL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FRIEDMAN PAUL A | Dir | — | $26.66M |
| 2 | Taub Rebecca | Dir | — | $21.68M |
| 3 | Sibold William John | Pres, CEO, Dir | — | $10.48M |
| 4 | BATE KENNETH | Dir | — | $8.03M |
| 5 | Levy Richard S | Dir | — | $7.36M |
| 6 | Dier Mardi | EVP, CFO | — | $3.77M |
| 7 | Huntsman Carole | Chief Commercial Off | — | $1.71M |
| 8 | Soergel David | Chief Medical Off | — | $952.0K |
| 9 | Kelley Shannon T | GC | — | $841.6K |
| 10 | Thakkar Rita | CAO | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-07 | 2025-11-05 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Dir | M - OptEx | $205.07 | +16.6K | 19.2K | +631% | +$3.40M |
| DM | 2025-11-07 | 2025-11-05 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Dir | S - Sale+OE | $484.31 | -16.6K | 8,896 | -65% | -$8.03M |
| DM | 2025-08-15 | 2025-08-15 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Dir | S - Sale+OE | $365.20 | -10.0K | 3,523 | -74% | -$3.65M |
| D | 2025-08-15 | 2025-08-15 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Dir | M - OptEx | $16.46 | +10.0K | 12.6K | +381% | +$164.6K |
| D | 2025-06-24 | 2025-06-20 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Dir | A - Grant | $0.00 | +715 | 2,627 | +37% | $0 |
| DM | 2025-02-28 | 2025-02-27 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Dir | S - Sale+OE | $356.44 | -20.0K | 21.8K | -48% | -$7.13M |
| DM | 2025-02-28 | 2025-02-27 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Dir | M - OptEx | $66.26 | +20.0K | 7,912 | New | +$1.33M |
| D | 2024-06-27 | 2024-06-25 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Dir | A - Grant | $0.00 | +714 | 1,912 | +60% | $0 |
| DM | 2024-04-03 | 2024-04-01+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Dir | S - Sale+OE | $252.86 | -32.5K | 1,472 | -96% | -$8.22M |
| DM | 2024-04-03 | 2024-04-01+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Dir | M - OptEx | $74.22 | +32.5K | 22.5K | New | +$2.41M |
| 2023-06-20 | 2023-06-15 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Dir | A - Grant | $0.00 | +1,198 | 1,198 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations